{"entity":{"id":"nct07016126","kind":"trial","name":"D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC","aka":[],"tldr":"A phase 3 trial in lung cancer, run by Guangdong Provincial People's Hospital, now recruiting.","summary":"D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC is a phase 3, interventional study registered as NCT07016126 by Guangdong Provincial People's Hospital, with a registry enrolment figure of 70 participants, started 2024-12-22 and due to reach its primary completion in 2027-12-22. Interventions recorded: D-BACE in combination with chemotherapy and karelizumab. Conditions listed: NSCLC (Non-small Cell Lung Cancer). Primary outcome: Evaluation of the pCR of resectable II-IIIA or potentially resectable T3-4N2 stage IIIB NSCLC treated with D-BACE in combination with chemotherapy and karelizumab. Lung eligibility wording from the registry: \"It is recommended that fresh tissue be fixed in 10% neutral buffered formalin for 24 to 48 hours The patient's lung function or other organ function was evaluated by the surgeon to tolerate local surgical treatment\". Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov NCT07016126","url":"https://clinicaltrials.gov/study/NCT07016126"}],"tags":["ctgov-ingest","lung-deep-dive"],"related":[],"cancers":["resectable-nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07016126","phase":"3","setting":"D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC","sponsor":"Guangdong Provincial People's Hospital","enrolled":70,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07016126/","neighbours":{"cancer":[{"id":"resectable-nsclc","kind":"cancer","name":"Resectable stage I to III non-small-cell lung cancer","route":"/cancers/resectable-nsclc/"}],"term":[{"id":"lung-trials-open-today","kind":"term","name":"Lung cancer trials open today (registry snapshot)","route":"/terms/lung-trials-open-today/"}]}}